2 drug(s) with this reaction
986 total reports
Cardiac Arrest has been reported as an adverse reaction across 2 drug(s) manufactured by Chattem Inc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 986 adverse event reports mention cardiac arrest in connection with Chattem Inc products.
This page provides a breakdown of which Chattem Inc drugs are most commonly associated with cardiac arrest, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Chattem Inc drugs have cardiac arrest listed in their FDA adverse event reports, sorted by report count:
In addition to cardiac arrest, the following adverse reactions have been reported across Chattem Inc's drug portfolio:
2 drug(s) manufactured by Chattem Inc have cardiac arrest listed in their FDA adverse event reports: LIDOCAINE, MENTHOL, LIDOCAINE HCL.
There are a combined 986 reports of cardiac arrest across 2 Chattem Inc drug(s) in the FDA adverse event database.